Diagnosis and treatment of HIV-associated nephropathy

Author： Betjes M.G.H.   Weening J.   Krediet R.T.  

Publisher： Elsevier

ISSN： 0300-2977

Source： The Netherlands Journal of Medicine, Vol.59, Iss.3, 2001-09, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction

By Rumbaugh Jeffrey A   Steiner Joseph   Sacktor Ned   Nath Avindra  

Future HIV Therapy, Vol. 2, Iss. 3, 2008-05 ,pp. : 271-280

Future Medicine

Access to resources Recommend Favorite

Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy

By Antoniou Tony   Raboud Janet   Kovacs Colin   Diong Christina   Brunetta Jason   Smith Graham   Halpenny Roberta   Beninger Francis   Loutfy Mona  

AIDS Care, Vol. 21, Iss. 10, 2009-10 ,pp. : 1247-1252

Routledge Ltd

Access to resources Recommend Favorite

Cost consequences of HIV-associated lipoatrophy

By Hornberger J.   Rajagopalan R.   Shewade A.   Loutfy M. R.  

AIDS Care, Vol. 21, Iss. 5, 2009-05 ,pp. : 664-671

Routledge Ltd

Access to resources Recommend Favorite

HIV-Associated Multiple Intracerebral Hemorrhages

By  

European Neurology, Vol. 53, Iss. 2, 2005-05 ,pp. : 100-102

Karger

Access to resources Recommend Favorite

Rituximab therapy for HIV-associated multicentric Castleman disease

By Veraitch Ophelia   Bower Mark   Shackleton David   Stebbing Justin  

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 281-284

Future Medicine

Access to resources Recommend Favorite